Calculated parenteral initial treatment of bacterial infections: Infections with multi-resistant Gram-negative rods - ESBL producers, carbapenemase-producing Enterobacteriaceae, carbapenem-resistant Acinetobacter baumannii.

GMS infectious diseases Pub Date : 2020-03-26 eCollection Date: 2020-01-01 DOI:10.3205/id000048
Béatrice Grabein, Michael Ebenhoch, Ernst Kühnen, Florian Thalhammer
{"title":"Calculated parenteral initial treatment of bacterial infections: Infections with multi-resistant Gram-negative rods - ESBL producers, carbapenemase-producing Enterobacteriaceae, carbapenem-resistant Acinetobacter baumannii.","authors":"Béatrice Grabein, Michael Ebenhoch, Ernst Kühnen, Florian Thalhammer","doi":"10.3205/id000048","DOIUrl":null,"url":null,"abstract":"<p><p>This is the sixteenth chapter of the guideline \"Calculated initial parenteral treatment of bacterial infections in adults - update 2018\" in the 2<sup>nd</sup> updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Infections due to multiresistant Gram-negative rods are challenging. In this chapter recommendations for targeted therapy for infections caused by ESBL-producing Enterobacteriaceae, carbapenemase-producing Enterobacteriaceae and carbapenem-resistant <i>Acinetobacter baumannii</i> are given, based on the limited available evidence.</p>","PeriodicalId":91688,"journal":{"name":"GMS infectious diseases","volume":"8 ","pages":"Doc04"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186793/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GMS infectious diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3205/id000048","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This is the sixteenth chapter of the guideline "Calculated initial parenteral treatment of bacterial infections in adults - update 2018" in the 2nd updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Infections due to multiresistant Gram-negative rods are challenging. In this chapter recommendations for targeted therapy for infections caused by ESBL-producing Enterobacteriaceae, carbapenemase-producing Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii are given, based on the limited available evidence.

Abstract Image

Abstract Image

Abstract Image

细菌感染的肠外初始治疗计算:多重耐药革兰氏阴性杆菌感染--ESBL 生产者、产碳青霉烯酶肠杆菌科细菌、耐碳青霉烯酶鲍曼不动杆菌。
这是《成人细菌感染的初始肠外治疗计算指南--2018 年更新版》第 2 次更新版中的第十六章。由保罗-埃利希化疗协会(Paul-Ehrlich-Gesellschaft für Chemotherapie e.V.,PEG)制定的德国指南已被翻译成国际版本。多重耐药革兰氏阴性杆菌引起的感染具有挑战性。本章将根据有限的现有证据,为产 ESBL 肠杆菌科细菌、产碳青霉烯酶肠杆菌科细菌和耐碳青霉烯类鲍曼不动杆菌引起的感染提供靶向治疗建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信